As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

U.S. airlines stand to reap the benefits as more passengers slim down thanks to the popularity of GLP-1 weight-loss drugs.

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s ...

A WOMAN who couldn’t fit into Primark leggings in their biggest size has now shed 8st thanks to Mounjaro. Lynsey Macfadyen, ...

Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.

Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Recognizing obesity as a chronic condition can improve treatment by shifting the focus to biological factors. Get to know obesity’s causes and care needs.

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: There’s not much research on B12 shots for weight loss ...